Deleterious BRCA1 or BRCA2 mutations may also moderately increase the risk of breast and prostate cancer in men [9], and pancreatic cancer [10,11] or colorectal cancer [12] in both sexes. Here, BRCA1 is linked to prostate carcinoma.